Segmed, a Palo, Alto, CA-based cloud-based real-world imaging platform that accelerates innovation in healthcare by simplifying access to medical data - announced that it closed $5.2 million seed+ funding.
The round was led by Nina Capital, with participation from iGan Partners, M3 Inc, Mighty Capital, Expeditions Fund, and Alchemist Accelerator, bringing the total funds raised to more than $10 million.
The funding will be used to continue working towards its mission: simplifying access to real-world imaging data.
The company also announced the launch of Segmed Insight. Segmed Insight was built to get high-quality, real-world medical imaging datasets into the hands of clinicians, researchers, and developers; particularly those seeking to train or validate their AI algorithms.
"The healthcare industry has become increasingly adoptive of artificial intelligence methods, but a roadblock in the development of unbiased, high-performing algorithms has been the timely acquisition of diverse, high-quality data," said Dr. Martin Willemink, CEO and co-founder at Segmed. "With Insight, our customers can massively cut down on data sourcing time, which in turn accelerates research and development in the medical field."
Medical researchers and AI developers using Segmed Insight can conduct a search, view studies and reports matching their search criteria, and construct datasets specific to their parameters.
Company: Segmed, Inc.
Raised: $5.2M
Round: Seed+ Round
Funding Month: November 2022
Lead Investors: Nina Capital
Additional Investors: iGan Partners, M3 Inc, Mighty Capital, Expeditions Fund, and Alchemist Accelerator
Company Website: https://www.segmed.ai/
Software Category: AI Data Platforms
About the Company: Founded in 2019 by Cailin Hardell, Adam Koszek, and Martin Willemink, Segmed is a cloud-based platform that curates medical data by anonymizing, standardizing, and labeling, to accelerate innovation in healthcare. Segmed provides a one-stop shop solution for medical AI companies to get medical image labels and accelerates the development of medical AI algorithms. Segmed's solution automates and streamlines the process and provides valuable, high-quality training datasets for AI models. By partnering with global healthcare providers; standardizing and de-identifying data via a sequence of proprietary algorithms; and allowing users to build customized datasets, Segmed has become a one-stop-shop for rapid medical data aggregation.
Source: https://www.prnewswire.com/news-releases/yc-and-alchemist-backed-segmed-raises-5-2m-funding-round-and-launches-medical-real-world-imaging-platform-301679080.html